The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
NDTV Profit on MSN
First-at-home Alzheimer's treatment: US FDA approves Eisai-Biogen's weekly self-injection
The injection is expected to be available by late August 2026 in the US.
Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...
The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Steroids, specifically corticosteroids, work by reducing inflammation that puts pressure on nerves and causes back pain. They lower levels of prostaglandins and other chemicals involved in the ...
Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results